{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:21:28Z","timestamp":1762323688138},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12020-013-0162-1","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T19:21:45Z","timestamp":1390418505000},"page":"308-314","source":"Crossref","is-referenced-by-count":31,"title":["Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?"],"prefix":"10.1007","volume":"47","author":[{"given":"Henrik","family":"Falhammar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,23]]},"reference":[{"issue":"4","key":"162_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.beem.2011.12.006","volume":"26","author":"G Arnaldi","year":"2012","unstructured":"G. Arnaldi, M. Boscaro, Adrenal incidentaloma. Best Pract. Res. Clin. Endocrinol. Metab. 26(4), 405\u2013419 (2012). doi: 10.1016\/j.beem.2011.12.006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"162_CR2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851\u2013870 (2011). doi: 10.1530\/EJE-10-1147","journal-title":"Eur. J. Endocrinol."},{"issue":"9477","key":"162_CR3","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","volume":"365","author":"DP Merke","year":"2005","unstructured":"D.P. Merke, S.R. Bornstein, Congenital adrenal hyperplasia. Lancet 365(9477), 2125\u20132136 (2005). doi: 10.1016\/S0140-6736(05)66736-0","journal-title":"Lancet"},{"issue":"3","key":"162_CR4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"H. Falhammar, M. Thoren, Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 41(3), 355\u2013373 (2012). doi: 10.1007\/s12020-011-9591-x","journal-title":"Endocrine"},{"key":"162_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000321223","volume":"20","author":"A Wedell","year":"2011","unstructured":"A. Wedell, Molecular genetics of 21-hydroxylase deficiency. Endocr Dev 20, 80\u201387 (2011). doi: 10.1159\/000321223","journal-title":"Endocr Dev"},{"issue":"2","key":"162_CR6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF03345586","volume":"31","author":"H Falhammar","year":"2008","unstructured":"H. Falhammar, M. Thoren, K. Hagenfeldt, A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation. J. Endocrinol. Investig. 31(2), 176\u2013180 (2008)","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"162_CR7","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"P.C. White, P.W. Speiser, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21(3), 245\u2013291 (2000)","journal-title":"Endocr. Rev."},{"issue":"3","key":"162_CR8","first-page":"685","volume":"74","author":"S Jaresch","year":"1992","unstructured":"S. Jaresch, E. Kornely, H.K. Kley, R. Schlaghecke, Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol Metab. 74(3), 685\u2013689 (1992)","journal-title":"J. Clin. Endocrinol Metab."},{"issue":"5","key":"162_CR9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2265.2000.00995.x","volume":"52","author":"TA Bachega","year":"2000","unstructured":"T.A. Bachega, A.E. Billerbeck, J.A. Marcondes, G. Madureira, I.J. Arnhold, B.B. Mendonca, Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 52(5), 601\u2013607 (2000)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"5","key":"162_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03347226","volume":"28","author":"H Falhammar","year":"2005","unstructured":"H. Falhammar, M. Thoren, An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence? J. Endocrinol. Investig. 28(5), 449\u2013453 (2005)","journal-title":"J. Endocrinol. Investig."},{"issue":"7","key":"162_CR11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF03346358","volume":"30","author":"L Barzon","year":"2007","unstructured":"L. Barzon, P. Maffei, N. Sonino, C. Pilon, L. Baldazzi, A. Balsamo, O. Del Maschio, G. Masi, M. Trevisan, M. Pacenti, F. Fallo, The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience. J. Endocrinol. Investig. 30(7), 615\u2013623 (2007)","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"162_CR12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1530\/eje.0.1360196","volume":"136","author":"M Reincke","year":"1997","unstructured":"M. Reincke, M. Peter, W.G. Sippell, B. Allolio, Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal \u2018incidentalomas\u2019. Eur. J. Endocrinol. 136(2), 196\u2013200 (1997)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"162_CR13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03343725","volume":"23","author":"M Toth","year":"2000","unstructured":"M. Toth, K. Racz, V. Adleff, I. Varga, L. Futo, C. Jakab, K. Karlinger, R. Kiss, E. Glaz, Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy. J. Endocrinol. Investig. 23(5), 287\u2013294 (2000)","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"162_CR14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1530\/EJE-11-0828","volume":"166","author":"H Falhammar","year":"2012","unstructured":"H. Falhammar, H.F. Nystrom, U. Ekstrom, S. Granberg, A. Wedell, M. Thoren, Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc. 166(3), 441\u2013449 (2012). doi: 10.1530\/EJE-11-0828","journal-title":"Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc."},{"key":"162_CR15","author":"I Nermoen","year":"2011","unstructured":"I. Nermoen, J. Rorvik, S.H. Holmedal, D.L. Hykkerud, K.J. Fougner, J. Svartberg, E.S. Husebye, K. Lovas, High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult norwegian patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. (2011). doi: 10.1111\/j.1365-2265.2011.04151.x","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"162_CR16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199809173391220","volume":"339","author":"G Russo","year":"1998","unstructured":"G. Russo, P. Paesano, G. Taccagni, A. Del Maschio, G. Chiumello, Ovarian adrenal-like tissue in congenital adrenal hyperplasia. N. Engl. J. Med. 339(12), 853\u2013854 (1998). doi: 10.1056\/NEJM199809173391220","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"162_CR17","first-page":"211","volume":"26","author":"H Selye","year":"1950","unstructured":"H. Selye, H. Stone, Hormonally induced transformation of adrenal into myeloid tissue. Am. J. Pathol. 26(2), 211\u2013233 (1950)","journal-title":"Am. J. Pathol."},{"issue":"7","key":"162_CR18","first-page":"2585","volume":"83","author":"F Beuschlein","year":"1998","unstructured":"F. Beuschlein, E. Schulze, P. Mora, H.P. Gensheimer, C. Maser-Gluth, B. Allolio, M. Reincke, Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. J. Clin. Endocrinol. Metab. 83(7), 2585\u20132588 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"162_CR19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2265.2002.01299.x","volume":"56","author":"SM Baumgartner-Parzer","year":"2002","unstructured":"S.M. Baumgartner-Parzer, S. Pauschenwein, W. Waldhausl, K. Polzler, P. Nowotny, H. Vierhapper, Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas. Clin. Endocrinol. 56(6), 811\u2013816 (2002)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"162_CR20","first-page":"55","volume":"83","author":"L Barzon","year":"1998","unstructured":"L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macri, M. Boscaro, Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J. Clin. Endocrinol. Metab. 83(1), 55\u201362 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"162_CR21","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"P.W. Speiser, R. Azziz, L.S. Baskin, L. Ghizzoni, T.W. Hensle, D.P. Merke, H.F. Meyer-Bahlburg, W.L. Miller, V.M. Montori, S.E. Oberfield, M. Ritzen, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(9), 4133\u20134160 (2010). doi: 10.1210\/jc.2009-2631","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-0162-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-0162-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-0162-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:46Z","timestamp":1559440606000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-0162-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-0162-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,23]]}}}